LYRM3 Antilichaam

LYRM3 Antibody: LYRM3, also known as NADH dehydrogenase (ubiquinone) 1 beta subcomplex 9 (NDUFB9), is a ubiquitously expressed LYR-motif containing protein. It has been suggested to be a candidate gene for the branchio-oto-renal (BOR) syndrome, which is characterized by branchial and renal abnormalities and heredity deafness disorders. Other than its LYR-motif, LYRM3 appears to have no functional or structural relationship to either LYRM1 or LYRM2.

4715

Q9Y6M9

Q9Y6M9

Human, Mouse, Rat

Unconjugated

Primary Antibodies

Homeostasis

LYRM3 Antibody is affinity chromatography purified via peptide column.

Cat. No. 1304 - Human Liver Tissue Lysate

1 mg/mL

Predicted species reactivity based on immunogen sequence: Bovine: (94%)

LYRM3 Antibody is supplied in PBS containing 0.02% sodium azide.

None

Blue Ice

LYRM3 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

IgG

NDUFB9

NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa

Homo sapiens

Lin X, Wells DE, Kimberling WJ, et al. Human NDUFB9 gene: genomic organization and a possible candidate gene associated with deafness disorder mapped to chromosome 8q13. Hum. Heredity1999; 49:75-80.

LYRM3 Antibody: B22, LYRM3, CI-B22, UQOR22, Complex I-B22

ELISA, WB, IHC-P, IF

8134589

Liquid